Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Englewood. Study-provided care at no cost to qualified participants.
Access alzheimer's disease specialists in Englewood at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
Xanamem® is being developed as a potential treatment for symptomatic, early stages of Alzheimer's Disease (AD) and Major Depressive Disorder (MDD). This XanaMIA Phase 2b/3 study is to investigate the safety, tolerability, and efficacy of Xanamem in in mild or moderate dementia due to AD. Trial participants will be randomized to either receive 10mg of Xanamem once daily or a placebo for 36 weeks at a 1:1 ratio in a double-blinded fashion.
Sponsor: Actinogen Medical
Check if you qualify for this alzheimer's disease clinical trial in Englewood, CO
If you're searching for alzheimer's disease treatment options in Englewood, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Englewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.